BioCryst Pharmaceuticals shares owned by EntryPoint Capital
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by EntryPoint Capital
from 13F filings
Historical chart of EntryPoint Capital investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by EntryPoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $99k | 13k | 7.80 |
| 2025-09-30 | $321k | 42k | 7.59 |
| 2025-06-30 | $350k | 39k | 8.96 |
| 2025-03-31 | $304k | 41k | 7.50 |
| 2024-09-30 | $409k | 54k | 7.60 |